Fostemavir Improves Outcomes for Treatment-Resistant HIV Patients - Contagionlive.com
7/30/2022 12:00:00 AM2 years 9 months ago
by Nina Cosdon
by Nina Cosdon
After 5 years of treatment, fostemsavir improved immunologic response and virologic outcome in patients with highly resistant HIV infection.
At the 24th International AIDS Conference (AIDS 2022), ViiV Healthcare announced positive 5-year data from their phase 3 trial for fostemsavir, a drug for multidrug-resistant HIV-1 infection. At week… [+3215 chars]
full article...